IRONWOOD PHARMACEUTICALS, INC. Depreciation
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Depreciation of $900.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-06
- IRONWOOD PHARMACEUTICALS, INC. depreciation for the quarter ending 2026-06-30 was $457.00K, a 2.14% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. depreciation for the quarter ending 2026-03-31 was $443.00K, a 7.52% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. depreciation for the quarter ending 2025-12-31 was $460.00K, a 5.15% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. depreciation for the quarter ending 2025-09-30 was $475.00K, a 6.31% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. depreciation for fiscal 2025 was $1.88M, a 6.46% decline from fiscal 2024.
- IRONWOOD PHARMACEUTICALS, INC. depreciation for fiscal 2024 was $2.01M, a 27.68% increase from fiscal 2023.
- IRONWOOD PHARMACEUTICALS, INC. depreciation for fiscal 2023 was $1.57M, a 11.07% increase from fiscal 2022.
- IRONWOOD PHARMACEUTICALS, INC. depreciation for fiscal 2022 was $1.42M, a 6.89% decline from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $457.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $900.00K 10-Q · filed 2026-08-06 | $1.36M derived: sum of 3 quarters · filed 2026-08-06 | $1.83M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $443.00K 10-Q · filed 2026-05-07 | $903.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.38M derived: sum of 3 quarters · filed 2026-05-07 | $1.84M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $460.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $935.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.40M derived: sum of 3 quarters · filed 2026-08-06 | $1.88M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $475.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $942.00K derived: sum of 2 quarters · filed 2026-08-06 | $1.42M 10-Q · filed 2025-11-10 | $1.91M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $467.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $946.00K 10-Q · filed 2026-08-06 | $1.43M derived: sum of 3 quarters · filed 2026-08-06 | $1.94M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $479.00K 10-Q · filed 2026-05-07 | $964.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.47M derived: sum of 3 quarters · filed 2026-05-07 | $1.98M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $485.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $992.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.50M derived: sum of 3 quarters · filed 2026-02-26 | $2.01M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $507.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.01M derived: sum of 2 quarters · filed 2025-11-10 | $1.53M 10-Q · filed 2025-11-10 | $2.04M derived: sum of 4 quarters · filed 2025-11-10 | |
| 2024-06-30 | $506.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $1.02M 10-Q · filed 2025-08-11 | $1.53M derived: sum of 3 quarters · filed 2025-08-11 | $2.04M derived: sum of 4 quarters · filed 2025-08-11 | |
| 2024-03-31 | $513.00K 10-Q · filed 2025-05-12 | $1.02M derived: sum of 2 quarters · filed 2025-05-12 | $1.53M derived: sum of 3 quarters · filed 2025-05-12 | $1.80M derived: sum of 4 quarters · filed 2025-05-12 | |
| 2023-12-31 | $512.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.02M derived: sum of 2 quarters · filed 2025-03-31 | $1.29M derived: sum of 3 quarters · filed 2025-03-31 | $1.57M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $507.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $777.00K derived: sum of 2 quarters · filed 2024-11-07 | $1.06M 10-Q · filed 2024-11-07 | $1.40M derived: sum of 4 quarters · filed 2025-03-31 | |
| 2023-06-30 | $270.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $556.00K 10-Q · filed 2024-08-08 | $896.00K derived: sum of 3 quarters · filed 2025-03-31 | $1.26M derived: sum of 4 quarters · filed 2025-03-31 | |
| 2023-03-31 | $286.00K 10-Q · filed 2024-05-09 | $626.00K derived: sum of 2 quarters · filed 2025-03-31 | $989.00K derived: sum of 3 quarters · filed 2025-03-31 | $1.35M derived: sum of 4 quarters · filed 2025-03-31 | |
| 2022-12-31 | $340.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $703.00K derived: sum of 2 quarters · filed 2025-03-31 | $1.06M derived: sum of 3 quarters · filed 2025-03-31 | $1.42M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $363.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $723.00K derived: sum of 2 quarters · filed 2023-11-09 | $1.08M 10-Q · filed 2023-11-09 | $1.44M derived: sum of 4 quarters · filed 2024-02-16 | |
| 2022-06-30 | $360.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $715.00K 10-Q · filed 2023-08-09 | $1.07M derived: sum of 3 quarters · filed 2024-02-16 | $1.43M derived: sum of 4 quarters · filed 2024-02-16 | |
| 2022-03-31 | $355.00K 10-Q · filed 2023-05-04 | $714.00K derived: sum of 2 quarters · filed 2024-02-16 | $1.07M derived: sum of 3 quarters · filed 2024-02-16 | $1.47M derived: sum of 4 quarters · filed 2024-02-16 | |
| 2021-12-31 | $359.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $717.00K derived: sum of 2 quarters · filed 2024-02-16 | $1.11M derived: sum of 3 quarters · filed 2024-02-16 | $1.52M 10-K · filed 2024-02-16 | |
| 2021-09-30 | $358.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $754.00K derived: sum of 2 quarters · filed 2022-11-03 | $1.16M 10-Q · filed 2022-11-03 | $1.58M derived: sum of 4 quarters · filed 2023-02-16 | |
| 2021-06-30 | $396.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $806.00K 10-Q · filed 2022-08-04 | $1.23M derived: sum of 3 quarters · filed 2023-02-16 | $3.05M derived: sum of 4 quarters · filed 2023-02-16 | |
| 2021-03-31 | $410.00K 10-Q · filed 2022-05-05 | $831.00K derived: sum of 2 quarters · filed 2023-02-16 | $2.65M derived: sum of 3 quarters · filed 2023-02-16 | $3.29M derived: sum of 4 quarters · filed 2023-02-16 | |
| 2020-12-31 | $421.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $2.24M derived: sum of 2 quarters · filed 2023-02-16 | $2.88M derived: sum of 3 quarters · filed 2023-02-16 | $3.56M 10-K · filed 2023-02-16 | |
| 2020-09-30 | $1.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $2.46M derived: sum of 2 quarters · filed 2021-11-04 | $3.14M 10-Q · filed 2021-11-04 | $4.01M derived: sum of 4 quarters · filed 2022-02-18 | |
| 2020-06-30 | $640.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.32M 10-Q · filed 2021-08-05 | $2.19M derived: sum of 3 quarters · filed 2022-02-18 | $5.36M derived: sum of 4 quarters · filed 2022-02-18 | |
| 2020-03-31 | $682.00K 10-Q · filed 2021-05-06 | $1.55M derived: sum of 2 quarters · filed 2022-02-18 | $4.72M derived: sum of 3 quarters · filed 2022-02-18 | $5.57M derived: sum of 4 quarters · filed 2022-02-18 | |
| 2019-12-31 | $867.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $4.04M derived: sum of 2 quarters · filed 2022-02-18 | $4.89M derived: sum of 3 quarters · filed 2022-02-18 | $5.58M 10-K · filed 2022-02-18 | |
| 2019-09-30 | $3.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $4.03M derived: sum of 2 quarters · filed 2020-11-05 | $4.71M 10-Q · filed 2020-11-05 | $5.41M derived: sum of 4 quarters · filed 2021-02-17 | |
| 2019-06-30 | $851.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $1.54M 10-Q · filed 2020-08-06 | $2.23M derived: sum of 3 quarters · filed 2021-02-17 | $3.21M derived: sum of 4 quarters · filed 2021-02-17 | |
| 2019-03-31 | $688.00K 10-Q · filed 2020-05-06 | $1.24M 10-Q · filed 2019-05-02 | $1.38M derived: sum of 2 quarters · filed 2021-02-17 | $2.36M derived: sum of 3 quarters · filed 2021-02-17 | $2.76M derived: sum of 4 quarters · filed 2021-02-17 |
| 2018-12-31 | $694.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $1.67M derived: sum of 2 quarters · filed 2021-02-17 | $2.07M derived: sum of 3 quarters · filed 2021-02-17 | $3.86M 10-K · filed 2021-02-17 | |
| 2018-09-30 | $976.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $1.38M derived: sum of 2 quarters · filed 2019-10-31 | $3.17M 10-Q · filed 2019-10-31 | ||
| 2018-06-30 | $399.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | $2.19M 10-Q · filed 2019-07-30 | |||
| 2018-03-31 | $1.79M 10-Q · filed 2019-05-02 | ||||
| 2017-12-31 | $6.44M 10-K · filed 2020-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |